Lymphangiogenesis is a phenomenon similar to angiogenesis, in which new lymphatic vessels are formed from pre-existing ones in a method termed sprouting that is initiated by the signaling molecule VEGF-C. Lymphangiogenesis is necessary in establishing homeostasis as well as metabolism and immunity, as many organs of the body require the vessels to transfer their dangerous and unnecessary cells to the lymph nodes in order to properly function. Lymphangiogenesis can, however, help in the progression of diseases such as rheumatoid arthritis, impaired wound healing, and cancer metastasis. If tumor cells are able to reach the lymphatic vessels, they can use them to further travel around the body to the lymph nodes, which can result in a lack of the disease fighting functions that the lymph nodes typically have.
Lymphangiogenesis Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Lymphangiogenesis below!
For more information on how to use Laverne, please read the How to Guide.
We have 2708 products for the study of the Lymphangiogenesis Pathway that can be applied to Chromatin Immunoprecipitation, Western Blot, Immunocytochemistry/Immunofluorescence, Flow Cytometry, Immunohistochemistry from our catalog of antibodies and ELISA kits.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.